{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:37:21Z","timestamp":1790951841662,"version":"4.1.0"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T00:00:00Z","timestamp":1416960000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0114053","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T22:55:49Z","timestamp":1417042549000},"page":"e114053","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry"],"prefix":"10.1371","volume":"9","author":[{"given":"Yun Gi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Won","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Young","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hwan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Seok","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Ho","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"D Sibbing","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/jth.12376","article-title":"Hematocrit alters VerifyNow P2Y12 assay results independently of intrinsic platelet reactivity and clopidogrel responsiveness","volume":"11","author":"N Kakouros","year":"2013","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1160\/TH09-05-0285","article-title":"The influence of clinical characteristics, laboratory and inflammatory markers on \u2018high on-treatment platelet reactivity' as measured with different platelet function tests","volume":"102","author":"EH Elsenberg","year":"2009","journal-title":"Thromb Haemost"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1160\/TH11-01-0046","article-title":"Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels","volume":"106","author":"S Voisin","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjcard.2011.11.049","article-title":"Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting","volume":"109","author":"C Toma","year":"2012","journal-title":"Am J Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"MS Sabatine","year":"2005","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2004.03.080","article-title":"Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial","volume":"44","author":"E Nikolsky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5551\/jat.20156","article-title":"Platelet volume indices are associated with high residual platelet reactivity after antiplatelet therapy in patients undergoing percutaneous coronary intervention","volume":"21","author":"YG Kim","year":"2014","journal-title":"J Atheroscler Thromb"},{"key":"ref9","first-page":"5","article-title":"Nutritional anaemias. Report of a WHO scientific group","volume":"405","year":"1968","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.amjcard.2010.01.001","article-title":"Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)","volume":"105","author":"K Tsujita","year":"2010","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction","volume":"50","author":"K Thygesen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","article-title":"Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial","volume":"57","author":"JW Suh","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2008.06.038","article-title":"Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study","volume":"52","author":"G Patti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up","volume":"119","author":"R Marcucci","year":"2009","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ahj.2010.10.036","article-title":"Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention","volume":"161","author":"YG Ko","year":"2011","journal-title":"Am Heart J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2011.08.019","article-title":"Platelet aggregation is dependent on platelet count in patients with coronary artery disease","volume":"129","author":"M Wurtz","year":"2012","journal-title":"Thromb Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"JP Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"MJ Price","year":"2011","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","article-title":"A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study","volume":"59","author":"D Trenk","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0114053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:53:26Z","timestamp":1589000006000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0114053"}},"subtitle":[],"editor":[{"given":"Andreas-Claudius","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,26]]},"references-count":19,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0114053","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,26]]}}}